CD14 C260T promoter polymorphism and the risk of cerebrovascular diseases: A meta-analysis

Journal of Applied Genetics

Volumn 50, Issue 2, 2009, Pages 153-157

  Banerjee, I ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

CD14; Cerebrovascular disease; Meta analysis; Polymorphism; Stroke

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 67149136302     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03195667     Document Type: Article

References (22)

1. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC, 2004. CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 90: 983-988.
2. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD, 1999. A polymorphism in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20: 976-983.
3. Banerjee I, Gupta V, Ahmed T, Faizaan M, Agarwal P, Ganesh S, 2008. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull 75: 158-165.
4. Begg CB, Mazumdar M, 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
5. Cochran WG, 1954. The combination of estimates from different experiments. Biometrics 10: 101-129.
6. DerSimonian R, Laird N, 1986. Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
7. Egger M, Davey SG, Schneider M, Minder C, 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
8. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, et al. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176: 1665-1671.
9. Hansson GK, Robertson AK, Söderberg-Nauclér C, 2006. Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329.
10. Hubacek JA, Rothe G, Pit'ha J, Skodová Z, Stanek V, Poledne R, Schmitz G, 1999. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99: 3218-3220.
11. Ito D, Murata M, Tanahashi N, Sato H, Sonoda A, Saito I, et al. 2000. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 31: 2661-2664.
12. Jawień J, 2008. New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn 118: 127-131.
13. Kis Z, Sas K, Gyulai Z, Treso B, Petrovay F, Kapusinszky B, et al. 2007. Chronic infections and genetic factors in the development of ischemic stroke. New Microbiol 30: 213-220.
14. Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Marculescu R, et al. 2006. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 44: 918-923.
15. Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dörfer C, Grau A, 2002. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. J Neurol 249: 821-823.
16. Loppnow H, Stelter F, Schönbeck U, Schlüter C, Ernst M, Schütt C, Flad HD, 1995. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 63: 1020-1026.
17. Mantel N, Haenszel W, 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
18. Park MH, Min JY, Koh SB, Kim BJ, Park MK, Park KW, Lee DH, 2006. Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke. Thromb Res 118: 671-677.
19. Schumann RR, Rietschel ET, Loppnow H, 1994. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol 183: 279-297.
20. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W, 1999. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 19: 932-938.
21. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC, 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249: 1431-1433.
22. Zee RY, Bates D, Ridker PM, 2002. A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke. Stroke 33: 892-895.